Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.
- Solara Active Pharma reported Total revenue for Q4 FY23 of ₹381 Crore, up from ₹361 Crore year on year depicting a growth of 6%.
- Total Expenses for Q4 FY23 of ₹332 Crore down, from ₹347 Crore year on year, a decline of 4%.
- Consolidated Net Profit of ₹3.76 Crore, up 108% from ₹1.81 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹1.05, up 102% from ₹0.52 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,